Search

Your search keyword '"Baker, Jason V"' showing total 404 results

Search Constraints

Start Over You searched for: Author "Baker, Jason V" Remove constraint Author: "Baker, Jason V"
404 results on '"Baker, Jason V"'

Search Results

2. Creating Effective Mobile Phone Apps to Optimize Antiretroviral Therapy Adherence: Perspectives From Stimulant-Using HIV-Positive Men Who Have Sex With Men

3. Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study

7. MAVMET trial: maraviroc and/or metformin for metabolic dysfunction-associated fatty liver disease(MAFLD) in adults with suppressed HIV

9. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial

11. The Current State of HIV and Aging: Findings Presented at the 10th International Workshop on HIV and Aging

14. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

17. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial

18. Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study.

20. Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy

21. Myocardial extracellular volume fraction is positively associated with activated monocyte subsets among cART-treated persons living with HIV in South Africa

22. CD8+ T-cells count in acute myocardial infarction in HIV disease in a predominantly male cohort.

24. HIV infection and cardiovascular disease in women.

25. Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV disease

26. Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort

29. HIV infection, antiretroviral therapy initiation and longitudinal changes in biomarkers of organ function.

30. Prehypertension, hypertension, and the risk of acute myocardial infarction in HIV-infected and -uninfected veterans.

31. Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.

34. Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START study

35. Beyond Undetectable: Modeling the Clinical Benefit of Improved Antiretroviral Adherence in Persons With Human Immunodeficiency Virus With Virologic Suppression

36. Health Maintenance

37. modeling the clinical benefit of improved antiretroviral adherence in persons with human immunodeficiency virus with virologic suppression

39. Corrigendum: Translating the observed differences in interleukin-6 levels between some antiretroviral regimens into potential long-term risk of serious non-AIDS events: A modeling study

41. Myocardial Extracellular Volume Fraction is Positively Associated with Activated Monocyte Subsets Among cART-Treated Persons Living with HIV in South Africa

45. Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015

47. Investigation of Causal Effects of Protein Biomarkers on Cardiovascular Disease in Persons With HIV

48. Translating the observed differences in interleukin-6 levels between some antiretroviral regimens into potential long-term risk of serious non-AIDS events: A modeling study

Catalog

Books, media, physical & digital resources